VVP
MEDP icon

Vulcan Value Partners’s Medpace MEDP Stock Holding History

Vulcan Value Partners’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$97.5M Buy
203,068
+155,762
+329% +$79.8M 2.58% 12
2025
Q4 		$26.6M Sell
47,306
-152,866
-76% -$86.8M 0.48% 29
2025
Q3 		$103M Sell
200,172
-87,287
-30% -$38.1M 1.87% 19
2025
Q2 		$96.9M Sell
287,459
-38,457
-12% -$11.5M 1.71% 19
2025
Q1 		$99.2M Buy
325,916
+224,578
+222% +$75.5M 1.86% 17
2024
Q4 		$33.7M Buy
101,338
+55,237
+120% +$18.7M 0.56% 31
2024
Q3 		$15.4M Buy
46,101
+7,501
+19% +$2.85M 0.26% 39
2024
Q2 		$15.9M Sell
38,600
-37,916
-50% -$15M 0.24% 39
2024
Q1 		$30.9M Sell
76,516
-25,744
-25% -$9.05M 0.45% 40
2023
Q4 		$31.3M Sell
102,260
-37,859
-27% -$10.2M 0.46% 39
2023
Q3 		$33.9M Sell
140,119
-51,889
-27% -$13.3M 0.52% 37
2023
Q2 		$46.1M Sell
192,008
-28,563
-13% -$5.93M 0.58% 32
2023
Q1 		$41.5M Buy
220,571
+67,229
+44% +$13.9M 0.52% 32
2022
Q4 		$32.6M Sell
153,342
-247,861
-62% -$49.5M 0.44% 33
2022
Q3 		$63.1M Sell
401,203
-14,605
-4% -$2.33M 0.74% 27
2022
Q2 		$62.2M Sell
415,808
-145,835
-26% -$21.1M 0.61% 30
2022
Q1 		$91.9M Buy
561,643
+329,023
+141% +$54.2M 0.56% 25
2021
Q4 		$50.6M Sell
232,620
-75,884
-25% -$15.9M 0.26% 35
2021
Q3 		$58.4M Buy
308,504
+83,328
+37% +$15.2M 0.31% 33
2021
Q2 		$39.8M Buy
+225,176
New +$38.9M 0.22% 37

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vulcan Value Partners's MEDP Position: Q1 2026 in Review

Vulcan Value Partners increased its Medpace (MEDP) stake by 329% in Q1 2026, buying an estimated $79.8M and bringing the position to 203,068 shares worth $97.5M. The position accounts for 2.58% of the portfolio, ranked #12.

Vulcan Value Partners first reported a position in MEDP in Q2 2021 and has held it in 20 quarters since. The position peaked at $103M in Q3 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Vulcan Value Partners held 203,068 shares of Medpace worth $97.5M as of Q1 2026.
  • Vulcan Value Partners bought 155,762 Medpace shares in Q1 2026, an estimated $79.8M.
  • Medpace made up 2.58% of Vulcan Value Partners's portfolio in Q1 2026, its #12 holding.
  • Vulcan Value Partners first reported a position in Medpace in Q2 2021 and has held it in 20 quarters since.
  • Vulcan Value Partners's Medpace position peaked at $103M in Q3 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Vulcan Value Partners's 13F filing for Q1 2026, filed 11 May 2026.